Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Sep;37(9):12589-12595.
doi: 10.1007/s13277-016-5124-9. Epub 2016 Jul 7.

Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma

Affiliations
Free article

Low absolute CD4+ T cell counts in peripheral blood are associated with inferior survival in follicular lymphoma

Lu He et al. Tumour Biol. 2016 Sep.
Free article

Abstract

Host immunity and tumor microenvironment significantly influence follicular lymphoma (FL) outcomes. Lymphopenia has been identified as a negative prognostic factor for FL. However, there is limited data regarding prognostic value of peripheral blood T lymphocyte subsets, especially absolute CD4+ T cell counts (ACD4C) in FL. We studied 127 consecutive FL patients to investigate whether peripheral blood ACD4C or absolute monocytes (AMC) at diagnosis had an impact on FL prognosis. In our cohort, both low ACD4C and high AMC were the parameters associated with inferior progression-free survival (PFS) (P = 0.021 and P = 0.013, respectively) and inferior overall survival (OS) (P = 0.020 and P = 0.005, respectively) by univariate analysis. Multivariate analysis revealed that only low ACD4C was statistically significant in worse PFS (hazard ratio, 2.811; 95 % confidence interval, 1.137-6.950; P = 0.025) and shorter OS (hazard ratio, 3.393; 95 % confidence interval, 1.037-11.105; P = 0.043) independent of FLIPI-2. Evaluation of blood ACD4C could be a useful indicator of outcome in previously untreated FL patients.

Keywords: CD4+ T cell counts; Follicular lymphoma; Monocyte counts; Overall survival; Progression-free survival.

PubMed Disclaimer

References

    1. J Hematol Oncol. 2011 Aug 15;4:34 - PubMed
    1. Blood. 2008 Jun 1;111(11):5359-70 - PubMed
    1. J Clin Oncol. 2007 Feb 10;25(5):579-86 - PubMed
    1. Ann Oncol. 2010 Jul;21(7):1486-91 - PubMed
    1. Br J Haematol. 2015 May;169(4):544-51 - PubMed

LinkOut - more resources